The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Reply from PR company, Anna Dunphy...."I'm in the process of sorting this out today. The presentation will be available soon so I'll let you know when it's up."
I have asked the company to post the slides that DB used in his presentation on Friday.
marve, try the Brave browser - it gets rid of all the crap when using the Browser and speeds up page loads etc. It even tells you how much time you have saved. I started using it a couple of months ago only and in that period I have saved over 6.5 hours in page refreshes in the browser. I highly recommend it.
btw, I don't think you have any shares so sell kelboy.....
Kelboy, you were saying a week ago you were on the verge of giving up, so why don't you do that and leave those with the patience to wait for the Sales orders.
Troy, its not going to make a dent in the number of PCR tests needed in India - every negative POC test has to be confirmed by a PCR test. India need to increase their testing by 5 to 10 fold for the size of their population.
Absolutely Posh. The new GDR PCR test is one of the very best, particularly for places like India where its temperature stability is key, not even considering its other USPs. Be patient, the sales will come through and anyone saying otherwise is just trying to grab your shares.
...13th June 14.02 and 14.05.
DrLong, video replay still not available. Look at my previous posts, I took some notes...
Its Avacta Group PLC
bigAl66, congratulations, you are a privileged participant in the Pillar 4 of the national testing strategy - 'Surveillance testing to learn more about the disease and help develop new tests and treatments', REACT-1 study. See slide/page 10 of the link below. I believe Wave 1 (baseline) covered the month of May. So Wave 2, I suggest covers, the month of June....
"https://www.bioindustry.org/uploads/assets/uploaded/e8486e01-60f6-4c6b-82a5aa69f105d507.pdf"
Something else I have not posted on this board, which some folks may find useful, may even drive some useful discussion eg around viral concentration. The FDA EUA list contained within is also a useful reference and it should grow with both the addition of Genedrive PCR tests and AVCT POC tests in the future. Both types of tests will complement each other and I think that will be supported in the Cytiva Webinar on Wednesday.
https://csb.mgh.harvard.edu/covid
PL75, it was in response to BarnetPeter's de-ramping on GDR and NCYT, hence only posted on those boards. Nothing more than that.
I have a view of Covid testing that encompasses all types of testing - PCR (Lab), PCR Mobile, POC antigen and Antibody. They all have their own role to play in the managing the spread of this virus. I may differ to some posters on here in the respect that I do not believe any one type of test will rule the Covid world, they will all have their place.
Deas, Covid-19 spread is so finely balanced in the UK.
On the day that lockdown began in the UK, Monday 23rd March, there were on average 11 new cases (per million of population) of Covid-19 per day (averaged over 7 days). The average over the last 7 days is over 20 news cases per day, still almost double. With the recent crowds (beaches, protests etc) over the past week the slow rate of decline of this number may well stall. Whilst the gradual release of lockdown continues in the UK over the next few weeks, even to keep the spread of the virus at this level will need huge amounts of continuous testing. So the UK market for PCR tests, mobile PCR testing, POC antigen tests, antibody tests is going to remain massive and even expand for the foreseeable future.
On the day that lockdown began in the UK, Monday 23rd March, there were on average 11 new cases (per million of population) of Covid-19 per day (averaged over 7 days). The average over the last 7 days is over 20 news cases per day, still almost double. With the recent crowds (beaches, protests etc) over the past week the slow rate of decline of this number may well stall. Whilst the gradual release of lockdown continues in the UK over the next few weeks, even to keep the spread of the virus at this level will need huge amounts of continuous testing. So the UK market for PCR tests, mobile PCR testing, POC antigen tests, antibody tests is going to remain massive and even expand for the foreseeable future.
Even though there are very great opportunities for GDR in the other 100 or so countries that have existing distribution paths, which GDR is no doubt pursuing, there is still such a great opportunity within the UK for the GDR product/s.
Agree marve, Barnet has is alternative modus operandi which is clear to see from his posts. Not worried about the 5-10% crowd....the traders feed on crumbs, investors eat the cake.
anofelli, not excluding these other countries of course.....
- Genedrive current distribution agreements -
Europe (CE Mark approved): Austria, Germany, UK, Switzerladn, Turkey, Spain, Portugal, Belgium, Netherlands, Luxembourg, Poland, Hungar, Czech Republic, Solovakia, Sweden, Norway, Denmark, France, Cyprus.
Central Europe (CE Mark Approved): Romania, Slovenia, Croatia, Ukraine, Estonia, Lithuania, Latvia, Moldova, Albania, Bulgaria, Serbia, Bosnia and Hercegovina, Montenegro.
Africa (WHO EUA applied): Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Congo, Democratic Republic of Congo, Cote d'Ivoire, Egypt, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Morocco, Mozambique, Namibia, Niger, Nigeria, Rwanda, Senegal, Seychelles, Sierra Leone, South Africa, South Sudan, Sudan, Swaziland, Togo, Tunisia, Uganda, Zambia, Zimbabwe.
Middle East: Iran, Iraq, Saudi Arabia, Yemen, Syria, UAE, Israel, Jordan, Palestine, Lebanon, Oman, Kuwait, Qatar, Armenia, Bahrain, Turkey, Azerbaijan, Uzbekistan, Tajikistan, Turkmenistan, Kyrgyzstan, Kosovo, Kazakhstan.
Desired Distribution Channels: USA (in progress, FDA approval applied), South America, Mexico.
PP, snap!...
PP, I'll send you one clue, take a look at this.....
https://testingmethods.crowdicity.com/post/3237330
I will let you DYOR on who Doris Ann-Williams is and her role within Lord Bethell's campaign sponsored by the UK Gov.